Jump to Content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report
Download Free Sample View Pricing
Home  ›  Healthcare & Medical Devices  ›  Antibiotic Resistance Market

Antibiotic Resistance Market Size & Growth Forecast 2026–2035, By Segments (Disease, Distribution Channel, Mechanism of Action, Drug Class, Pathogen), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14026| Published Date: Jun-2026| Format: PDF, Excel
Report Description Table of Contents (ToC) Request Free Sample Report →
Table of Contents (ToC)

Chapter 1. Methodology and Scope

  • Methodology segmentation & scope
  • Market Definitions
  • Research Methodology
  • Research Scope and Assumptions

Chapter 2. Executive Summary

  • Market Outlook
  • Segment Outlook
  • Competitive Insights

Chapter 3. Antibiotic Resistance Industry Insights

  • Market Introduction
  • Industry Value Chain Analysis
  • Market Dynamics
    • Market Drivers Analysis
    • Market Restraints Analysis
    • Industry Opportunities
  • Regulatory Framework
  • Analysis Tools
    • Porter’s Analysis
      • Bargaining Power of the Suppliers
      • Bargaining Power of the Buyers
      • Threats of Substitution
      • Threats From New Entrants
    • PESTEL Analysis
      • Political Landscape
      • Economic and Social Landscape
      • Technological Landscape
      • Environmental Landscape
      • Legal Landscape

Chapter 4. Antibiotic Resistance Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Disease

  • cUTI (Complicated Urinary Tract Infections) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • CDI (Clostridioides Difficile Infection) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • ABSSSI (Acute Bacterial Skin and Skin Structure Infections) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • HABP (Hospital-acquired Bacterial Pneumonia) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • CABP (Community-acquired Pneumonia) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • cIAI (Complicated Intra-Abdominal Infection) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • BSI (Bloodstream Infection) Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 5. Antibiotic Resistance Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Distribution Channel

  • Hospital Pharmacies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Retail Pharmacies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Online Pharmacies Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 6. Antibiotic Resistance Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Mechanism of Action

  • Protein Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Cell Wall Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • RNA Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • DNA Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 7. Antibiotic Resistance Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Drug Class

  • Oxazolidinones Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Lipoglycopeptides Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Tetracyclines Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Combination Therapies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Cephalosporins Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 8. Antibiotic Resistance Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Pathogen

  • E. Coli Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • K. Pneumoniae Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • P. Aeruginosa Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • S. Aureus Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • A. Baumannii Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • S. Pneumoniae Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • H. Influenzae Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • C. Difficile Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • E. Faecium Segment Estimates and Forecasts, 2022–2035 (USD Billion)

Chapter 9. Antibiotic Resistance Market Estimates 2022–2035 (USD Billion) & Trend Analysis, by Region & Countries

  • Antibiotic Resistance Share, By Region
  • North America
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • U.S.
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Canada
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
  • Europe
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • UK
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Germany
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • France
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Italy
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Spain
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Russia
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
  • Asia Pacific
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • China
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • India
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Japan
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Australia
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • South Korea
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
  • Latin America
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Mexico
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Brazil
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Argentina
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
  • Middle East & Africa
    • Market Estimates and Forecasts, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
    • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • Saudi Arabia
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • UAE
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)
    • South Africa
      • Market Estimates and Forecasts, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Disease, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Distribution Channel, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Mechanism of Action, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Drug Class, 2022–2035 (USD Billion)
      • Market Estimates and Forecast by Pathogen, 2022–2035 (USD Billion)

Chapter 10. Competitive Landscape

  • Company Overview
  • Company Market Share Analysis
  • Company Heat Map Analysis
  • Company SWOT Analysis
  • Company Financial Performance
  • Strategy Mapping
    • Expansion
    • Mergers & Acquisition
    • Partnerships & Collaborations
    • New Product Launches
    • Research and Development
  • Company Profiles
    • Merck & Co. Inc. (United States)
    • Pfizer Inc. (United States)
    • GlaxoSmithKline plc (United Kingdom)
    • Johnson & Johnson (United States)
    • F. Hoffmann-La Roche Ltd (Switzerland)
    • Shionogi & Co. Ltd. (Japan)
    • Astellas Pharma Inc. (Japan)
    • Melinta Therapeutics LLC (United States)
    • Paratek Pharmaceuticals Inc. (United States)
    • Entasis Therapeutics Holdings Inc. (United States)

List of Tables

  • Global Antibiotic Resistance Market, 2022–2035 (USD Billion)
  • Global Antibiotic Resistance Market, by Region, 2022–2035 (USD Billion)
  • Global Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Global Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Global Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Global Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Global Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • cUTI (Complicated Urinary Tract Infections) Segment by Region, 2022–2035 (USD Billion)
  • CDI (Clostridioides Difficile Infection) Segment by Region, 2022–2035 (USD Billion)
  • ABSSSI (Acute Bacterial Skin and Skin Structure Infections) Segment by Region, 2022–2035 (USD Billion)
  • HABP (Hospital-acquired Bacterial Pneumonia) Segment by Region, 2022–2035 (USD Billion)
  • CABP (Community-acquired Pneumonia) Segment by Region, 2022–2035 (USD Billion)
  • cIAI (Complicated Intra-Abdominal Infection) Segment by Region, 2022–2035 (USD Billion)
  • BSI (Bloodstream Infection) Segment by Region, 2022–2035 (USD Billion)
  • Hospital Pharmacies Segment by Region, 2022–2035 (USD Billion)
  • Retail Pharmacies Segment by Region, 2022–2035 (USD Billion)
  • Online Pharmacies Segment by Region, 2022–2035 (USD Billion)
  • Protein Synthesis Inhibitors Segment by Region, 2022–2035 (USD Billion)
  • Cell Wall Synthesis Inhibitors Segment by Region, 2022–2035 (USD Billion)
  • RNA Synthesis Inhibitors Segment by Region, 2022–2035 (USD Billion)
  • DNA Synthesis Inhibitors Segment by Region, 2022–2035 (USD Billion)
  • Others Segment by Region, 2022–2035 (USD Billion)
  • Oxazolidinones Segment by Region, 2022–2035 (USD Billion)
  • Lipoglycopeptides Segment by Region, 2022–2035 (USD Billion)
  • Tetracyclines Segment by Region, 2022–2035 (USD Billion)
  • Combination Therapies Segment by Region, 2022–2035 (USD Billion)
  • Cephalosporins Segment by Region, 2022–2035 (USD Billion)
  • Others Segment by Region, 2022–2035 (USD Billion)
  • E. Coli Segment by Region, 2022–2035 (USD Billion)
  • K. Pneumoniae Segment by Region, 2022–2035 (USD Billion)
  • P. Aeruginosa Segment by Region, 2022–2035 (USD Billion)
  • S. Aureus Segment by Region, 2022–2035 (USD Billion)
  • A. Baumannii Segment by Region, 2022–2035 (USD Billion)
  • S. Pneumoniae Segment by Region, 2022–2035 (USD Billion)
  • H. Influenzae Segment by Region, 2022–2035 (USD Billion)
  • C. Difficile Segment by Region, 2022–2035 (USD Billion)
  • E. Faecium Segment by Region, 2022–2035 (USD Billion)
  • North America Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • North America Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • North America Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • North America Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • North America Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • U.S. Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • U.S. Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • U.S. Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • U.S. Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • U.S. Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Canada Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Canada Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Canada Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Canada Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Canada Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Europe Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Europe Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Europe Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Europe Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Europe Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • UK Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • UK Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • UK Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • UK Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • UK Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Germany Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Germany Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Germany Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Germany Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Germany Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • France Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • France Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • France Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • France Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • France Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Italy Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Italy Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Italy Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Italy Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Italy Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Spain Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Spain Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Spain Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Spain Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Spain Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Russia Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Russia Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Russia Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Russia Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Russia Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Asia Pacific Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Asia Pacific Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Asia Pacific Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Asia Pacific Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Asia Pacific Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • China Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • China Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • China Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • China Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • China Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • India Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • India Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • India Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • India Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • India Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Japan Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Japan Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Japan Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Japan Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Japan Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Australia Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Australia Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Australia Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Australia Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Australia Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • South Korea Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • South Korea Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • South Korea Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • South Korea Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • South Korea Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Latin America Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Latin America Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Latin America Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Latin America Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Latin America Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Mexico Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Mexico Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Mexico Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Mexico Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Mexico Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Brazil Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Brazil Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Brazil Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Brazil Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Brazil Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Argentina Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Argentina Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Argentina Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Argentina Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Argentina Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Middle East & Africa Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Middle East & Africa Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Middle East & Africa Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Middle East & Africa Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Middle East & Africa Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • UAE Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • UAE Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • UAE Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • UAE Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • UAE Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • Saudi Arabia Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • Saudi Arabia Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • Saudi Arabia Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • Saudi Arabia Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • Saudi Arabia Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)
  • South Africa Antibiotic Resistance Market, by Disease, 2022–2035 (USD Billion)
  • South Africa Antibiotic Resistance Market, by Distribution Channel, 2022–2035 (USD Billion)
  • South Africa Antibiotic Resistance Market, by Mechanism of Action, 2022–2035 (USD Billion)
  • South Africa Antibiotic Resistance Market, by Drug Class, 2022–2035 (USD Billion)
  • South Africa Antibiotic Resistance Market, by Pathogen, 2022–2035 (USD Billion)

List of Figures

  • Market Snapshot
  • Segment Snapshot
  • Competitive Landscape Snapshot
  • Industry Value Chain Analysis
  • Market Dynamics
  • PORTER’s Analysis
  • PESTEL Analysis
  • Antibiotic Resistance Market Estimates and Forecasts, 2022–2035 (USD Billion), by Disease
  • cUTI (Complicated Urinary Tract Infections) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • CDI (Clostridioides Difficile Infection) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • ABSSSI (Acute Bacterial Skin and Skin Structure Infections) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • HABP (Hospital-acquired Bacterial Pneumonia) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • CABP (Community-acquired Pneumonia) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • cIAI (Complicated Intra-Abdominal Infection) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • BSI (Bloodstream Infection) Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Antibiotic Resistance Market Estimates and Forecasts, 2022–2035 (USD Billion), by Distribution Channel
  • Hospital Pharmacies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Retail Pharmacies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Online Pharmacies Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Antibiotic Resistance Market Estimates and Forecasts, 2022–2035 (USD Billion), by Mechanism of Action
  • Protein Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Cell Wall Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • RNA Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • DNA Synthesis Inhibitors Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2035 (USD Billion)
  • Antibiotic Resistance Market Estimates and Forecasts, 2022–2035 (USD Billion)

Get more details on this report

Request Free Sample Report

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →